论文部分内容阅读
目的:采用普适性健康量表(SF-36量表)结合慢性肝病生存质量量表(CLDQ量表)对肝硬化住院患者生存质量进行比较评价。方法:采用SF-36量表与CLDQ量表对我院感染科住院病人50例肝硬化患者及性别、年龄相匹配的50例健康对照组进行问卷调查,对调查结果运用spss17.0中文版进行T检验、相关性分析等处理。结果:肝硬化组在SF-36量表及CLDQ量表的各个维度上得分及总分均低于健康对照组,P<0.05,差异有统计学意义;SF-36量表与CLDQ量表各维度之间相互的相关性分析是存在显著的相关性。结论:SF-36量表与CLDQ量表均能反映肝硬化住院患者生存质量受损情况,结合两个量表使用既反映肝硬化患者肝病症状,又能对患者进行整体护理的评估,在评价肝硬化患者的生存质量时最好同时使用两种量表。
OBJECTIVE: To evaluate the quality of life of patients with cirrhosis in hospital by using the Universal Health Scale (SF-36) and the Chronic Liver Disease Quality of Life Scale (CLDQ). Methods: Fifty patients with cirrhosis in our hospital and 50 healthy control subjects of gender and age were surveyed by SF-36 scale and CLDQ scale. The results of the questionnaire were analyzed using Chinese version of spss17.0 T test, correlation analysis and other treatment. Results: The score and total score of SF-36 scale and CLDQ scale of cirrhosis group were lower than those of healthy control group, P <0.05, the difference was statistically significant; SF-36 scale and CLDQ scale There is a significant correlation between the correlations of the dimensions of each other. Conclusion: SF-36 scale and CLDQ scale can reflect the quality of life of patients with cirrhosis hospitalized deterioration, combined with the use of two scales in patients with liver cirrhosis not only reflect the symptoms of liver disease, but also the overall patient care assessment, evaluation The quality of life in patients with cirrhosis is best to use both scales.